About Wenxuan Wu
Form D filings for CytoTronics in 2024 list Wenxuan Wu as executive officer and director.
Wenxuan Wu first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Wenxuan Wu in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Wenxuan Wu works with at each company, as listed on that company's latest Form D.
CytoTronics, Inc. · Form D, Oct 11, 2024
SR
Sameer Rohatgi
Director
JA
Jeffrey Abbott
Chief Executive Officer and director
DK
Douglas Kahn
Director
JA
Jenna Abelli
Director